货号：UP707880996
| 产品信息 | |
| 产品名称： | Nafamostat |
| 中文名称： | (请以英文为准,中文仅做参考) |
| CAS号： | 81525-10-2 |
| 分子式： | C19H17N5O2 |
| 分子量： | 347.37 |
| MDL NO： | - |
| 标准纯度： | 98+% (UP707880996) |
| 沸点： | 637.2°C at 760 mmHg |
| 储存： | (UP707880996) |
| Pubchem ID： | - |
| ACS编号： | - |
| InChIKey： | - |
| Clogp | - |
| 英文别名： | - |
| 中文别名 | - |
2-(Hydroxymethyl)-1H-benzo[d]imidazole-5-sulfonic acid hydrochloride
UP2624094941158496-77-5
Butyl 4-methylbenzenesulfonate
UP604449664778-28-9
4-Methyl-1H-benzo[d]imidazole-2-sulfonic acid
UP2321592641071368-98-3
Radotinib
UP637772560926037-48-1
Primidone
UP132914828125-33-7
Dasatinib
UP697154108302962-49-8
Saracatinib
UP369881492379231-04-6
6-Chloro-2-phenyl-5-(trifluoromethyl)-1H-benzo[d]imidazol-1-ol
UP5971171361203898-20-7
ZM306416
UP365637644690206-97-4
3,4-Difluoronitrobenzene
UP425922831369-34-6
ON 146040
UP2980523221404231-34-0
Nilotinib monohydrochloride monohydrate
UP127512419923288-90-8
2,4,4,6-Tetramethyl-5,6-dihydro-4H-1,3-oxazine
UP13769405726939-18-4
5-Bromo-1,2,3,4-tetrahydroquinoline
UP772351379114744-50-2
Ponatinib
UP243655843943319-70-8
EMD638683
UP8491420971181770-72-8
WP1130
UP353973040856243-80-6
6-(3-(p-Tolyl)-1,2,4-oxadiazol-5-yl)-4,5-dihydropyridazin-3(2H)-one
UP3654043221260934-79-9
3-(6-Chloropyridazin-3-yl)-1H-indole
UP227438472129287-26-9
Isopropyl cyclopropanesulfonate
UP264497186146475-51-6
Butyl methanesulfonate
UP6791600971912-32-9
Isopropyl 4-methylbenzenesulfonate
UP8706717462307-69-9
5-Chloropyridazine-3-carboxylic acid
UP8308804271211587-01-7
Methyltriphenylphosphonium iodide
UP9947694922065-66-9
Ethane-1,2-diyl bis(4-methylbenzenesulfonate)
UP6560523256315-52-2
Benzo[d]thiazole
UP25398853495-16-9
4-Bromo-2,5-dichloropyridine
UP82430926541184917-16-5
1,3,2-Dioxathiolane 2,2-dioxide
UP8965609611072-53-3
Methyl methanesulfonate
UP21681404966-27-3
Methanesulfonic anhydride
UP2977097147143-01-3
DCC-2036
UP7639692351020172-07-9
Flumatinib
UP660656191895519-90-1
AZD1208
UP9042552541204144-28-4
4-Methylbenzenesulfonic anhydride
UP1701968174124-41-8
2-Chloro-5-methylpyrazine
UP99930481159303-10-5
Almitrine mesylate
UP13687020429608-49-9
LY2228820
UP797600629862507-23-1
2-(2-(Pyridin-2-yl)disulfanyl)ethanol
UP7666572845111625-28-6
AZ 191
UP8940155881594092-37-1
Methyl ethanesulfonate
UP2310197121912-28-3
6-Ethoxypyridazin-3-amine
UP28883029439614-78-3
Isopropyl methanesulfonate
UP713096616926-06-7
TCS-PIM-1-4a
UP557784330327033-36-3
5-Amino-2-methyl-2H-tetrazole
UP4502971566154-04-7
NVP-BHG712
UP169834894940310-85-0
HJC0350
UP445082080885434-70-8
2-((6-Chloropyridazin-3-yl)methyl)isoindoline-1,3-dione
UP687613250948996-03-0
sec-Butyl 4-methylbenzenesulfonate
UP253099223715-11-7
6-Oxo-1,6-dihydropyridazine-4-carboxylic acid
UP337336330867130-58-3
Hexyl methanesulfonate
UP77210716816156-50-6
Tolcapone
UP394184615134308-13-7
Cabozantinib
UP307446679849217-68-1
EX-527 S-Enantiomer
UP428540378848193-68-0
3-Pyridinecarboxylic acid, 6-ethenyl-, phenylmethyl ester
UP67928237551268451-78-0
Pazopanib
UP954484494444731-52-6
1-Ethyl-7-nitro-1,2,3,4-tetrahydroquinoline
UP21037782257883-28-0
Arginase inhibitor 1
UP8044630711345808-25-4
2-Phenyl-1H-imidazole
UP573443286670-96-2
Nafamostat
UP70788099681525-10-2